Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    eplerenone | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Eplerenone for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: Eplerenone 50mg
2 Recruiting Eplerenone in the Management of Abdominal Aortic Aneurysms
Condition: Aortic Aneurysm, Abdominal
Intervention: Drug: Eplerenone
3 Recruiting Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Eplerenone
4 Recruiting PHOspholamban RElated CArdiomyopathy STudy - Intervention
Condition: Phospholamban R14del Mutation-related Cardiomyopathy
Intervention: Drug: Eplerenone
5 Recruiting Cardiometabolic Effects of Eplerenone in HIV Infection
Conditions: Cardiac Steatosis;   Hepatic Steatosis
Intervention: Drug: Inspra /Eplerenone
6 Not yet recruiting A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Eplerenone;   Drug: Maltodextrin
7 Not yet recruiting Pharmacokinetics Study of Eplerenone Coated Tablets
Conditions: Pharmacokinetics;   Healthy Subjects;   Fasting
Intervention: Drug: eplerenone
8 Recruiting Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial
Condition: Atherosclerosis
Interventions: Drug: Eplerenone;   Drug: Placebo
9 Not yet recruiting Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)
Condition: End-stage Renal Disease
Interventions: Drug: Eplerenon;   Drug: Placebo
10 Recruiting The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)
Condition: CKD II-III
Interventions: Drug: Eplerenone;   Drug: Placebo
11 Recruiting Study of CS-3150 in Patients With Essential Hypertension
Condition: Essential Hypertension
Interventions: Drug: CS-3150;   Drug: Eplerenone
12 Not yet recruiting Pharmacokinetics of Eplerenone Tablet
Condition: Healthy Volunteers
Interventions: Drug: Eplerenone 25 mg;   Drug: Eplerenone 50 mg;   Drug: Eplerenone 100 mg;   Drug: Eplerenone 50 mg twice a day;   Drug: Eplerenone 25 mg twice a day
13 Recruiting Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Eplerenone;   Drug: Spironolactone
14 Recruiting Aldosterone Antagonism and Microvascular Function
Conditions: Abdominal Obesity Metabolic Syndrome;   Insulin Resistance;   Hypertension
Interventions: Drug: Eplerenone;   Other: Placebo
15 Not yet recruiting Effects of Eplerenone on Cardiovascular Disease in HIV (MIRACLE HIV Study)
Condition: HIV
Interventions: Drug: Eplerenone;   Drug: Placebo;   Behavioral: Lifestyle Modification
16 Not yet recruiting Detection of Diffuse Scar in Patients With Diabetes
Condition: Diabetes Mellitus, Type II
Interventions: Drug: Eplerenone;   Drug: Placebo
17 Recruiting Hypoglycemia and the Mineralocorticoid Receptor
Condition: Hypoglycemia
Intervention: Drug: Eplerenone
18 Recruiting Mineralocorticoid Receptor Antagonists in Type 2 Diabetes
Condition: Diabetes Type 2
Interventions: Drug: Eplerenone;   Drug: Placebo
19 Recruiting The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
Condition: Hypertension
Interventions: Drug: Eplerenone;   Drug: Amlodipine;   Procedure: Microneurography;   Procedure: Rhythmic handgrip exercise;   Procedure: Sustained hand grip;   Procedure: Forearm blood flow;   Procedure: Arm cycling exercise;   Procedure: Cold Pressor test
20 Recruiting Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism
Condition: Primary Hyperparathyroidism
Interventions: Drug: eplerenone;   Drug: amiloride;   Drug: Placebo;   Drug: Cinacalcet

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.